GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

Chief Executive Tim Wentworth said the second-quarter results reflected cost management and improvement in U.S. healthcare, though partially offset by weaker front-rend results in U.S. retail pharmacy ...

LucyRx, a next-generation pharmacy benefits manager (PBM), announced the expansion of its network of specialty pharmacies.

Chief Executive Tim Wentworth said the second-quarter results reflected cost management and improvement in U.S. healthcare, though partially offset by weaker front-rend results in U.S. retail pharmacy ...

Learn more about whether Organon & Co. or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.

With half of hospital admissions for pneumonia affecting young and middle-aged adults, experts emphasize ...

A WOMAN who was secretly taking weight loss jabs says she now feels “better than ever” – but her husband was “furious” after ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Viatris Inc. is a better investment based on AAII's A+ Investor ...

Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, and virtual primary care company in the market. The combined ...